Mechanism of action and receptor targets
The mechanism of action of the drug is based on the selective blockade of a strictly defined pool of receptors in central nervous system structures. First of all, the molecule binds to central serotonin $5-HT_{2A}$ receptors and dopamine $D_2$ receptors. In addition, the drug is capable of blocking $\alpha$-adrenoceptors and histamine $H_1$ receptors.
However, the most important clinical feature of its receptor profile lies in the targets that the drug does not affect. It has been proven that it practically does not interact with muscarinic acetylcholine receptors. In clinical practice, this is of critical importance. The fact is that the concomitant anticholinergic effect of many other drugs helps mitigate or prevent the development of extrapyramidal symptoms (movement disorders). Due to the complete absence of such a "protective" anticholinergic effect, therapy with this agent causes extrapyramidal disorders much more frequently than treatment with other atypical antipsychotics.
Dose-dependent pharmacodynamics
An interesting feature of the molecule is the dependence of its pharmacological properties on the administered dose. Experimental data show that the classification of the drug can literally change depending on the quantity in which it enters the body. This phenomenon is based on a change in the receptor blockade ratio (the ratio of blockade of serotonin and dopamine targets).
- Use in low doses: in this regimen, the substance exhibits the classical properties of an atypical antipsychotic, providing an antipsychotic effect with a minimal risk of severe neurological disorders.
- Use in high doses: with increasing concentration, the action profile shifts dramatically. The drug begins to behave like a typical antipsychotic. Clinically, this is manifested by the patient's high propensity to develop severe extrapyramidal disorders.
Pharmacokinetics and active metabolite
The pharmacokinetic parameters of the drug determine the convenience of its use in routine medical practice. After entering the systemic circulation, the parent substance undergoes active metabolism. The main result of this process is the formation of an active metabolite named 9-hydroxyrisperidone.
The key characteristic of this metabolite is its half-life ($t_{1/2}$). For 9-hydroxyrisperidone, this parameter is significantly greater than that of the parent substance itself, reaching 24 hours.
The practical significance of this pharmacokinetic fact cannot be overstated. Due to the prolonged circulation of the active metabolite in the blood, the need for frequent tablet intake is eliminated. The physician is able to prescribe the drug just once a day, while the therapeutic concentration and antipsychotic effect will remain at a stable level throughout the day.
Clinical application
In clinical practice, the drug has a clearly defined niche. The primary and main indication for its prescription is the comprehensive treatment of schizophrenia.
The drug is of particular value in the management of complex psychiatric patients. It demonstrates high clinical efficacy in treatment-resistant forms of the disease. In particular, it is successfully used in cases where the pathology proves completely resistant to therapy with classical potent antipsychotics such as haloperidol.
Briefly: answers to topical questions
What are the indications for risperidone?
Risperidone is used to treat a wide range of psychiatric, neurological, and somatic disorders. The main indication is the treatment of schizophrenia, including treatment-resistant forms refractory to haloperidol therapy.
The drug is prescribed in the following cases:
- Relief of positive symptoms — reduction of delusions, hallucinations, and catatonic disorders.
- Containment of negative symptoms — mitigation of autism, passivity, and activation of patients with an apatico-abulic defect.
- Behavioral correction — in psychopathies, neuroses, organic diseases, and autism spectrum disorders.
- Treatment of somatic disorders — therapy of pruritus in chronic skin diseases.
- Interruption of an acute attack — containment of the progression of the malignant schizophrenic process.
What side effects does risperidone cause?
Risperidone is capable of causing neurological side effects, as well as exerting a pronounced sedative effect.
Main adverse reactions include:
- Extrapyramidal disorders — occur more frequently than with other atypical antipsychotics due to the absence of anticholinergic activity. The ability to cause these disorders manifests when the drug is used in high doses, when it begins to demonstrate the properties of a typical antipsychotic.
- Sedative effect — is a significant limitation when using the drug as an antihistamine agent.
At the same time, the overall probability of developing neuroleptic malignant syndrome with risperidone is significantly lower than with typical antipsychotics.
To easily memorize the receptor profile of the drug for the exam, use a simple mnemonic phrase: «Serotonin and Dopamine Attack Histamine, but go Past Choline». This formula decodes as follows: the drug blocks Serotonin, Dopamine, Alpha-adrenergic receptors and Histamine receptors, but is characterized by a complete lack of effect on M-Cholinergic receptors (which is the reason for frequent side effects).
Class and exam questions
Why does the drug provoke extrapyramidal disorders more often than other atypical agents?
The main reason lies in the peculiarities of its receptor profile. The drug practically does not affect muscarinic receptors. In psychopharmacology, it is the concomitant anticholinergic action that helps mitigate extrapyramidal symptoms. Since this effect is absent here, the risk of movement disorders increases.
How does dosage affect the pharmacological class of the drug?
When the dose changes, the blockade ratio of serotonin and dopamine receptors changes. If in low doses the agent acts as a mild atypical antipsychotic, then in high doses it acquires the properties of a typical antipsychotic, which is accompanied by the appearance of extrapyramidal disorders.
How is it possible to take the medication only once a day?
The parent substance in the body is transformed into an active metabolite, 9-hydroxyrisperidone. The half-life of this metabolite is 24 hours, which significantly exceeds the lifespan of the drug itself and ensures the long-term persistence of the therapeutic effect.
What else to study on this topic
- Detailed analysis of the mechanism of selective blockade of serotonin (5-HT2A) and dopamine (D2) receptors.
- Pathogenesis of extrapyramidal disorders against the background of the absence of antimuscarinic activity.
- Significance of the serotonin/dopamine blockade ratio for the classification of antipsychotics.
- Pharmacokinetics of 9-hydroxyrisperidone: pathways of formation and elimination features.
- Criteria for treatment-resistant schizophrenia and tactics for switching patients from haloperidol.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Risperidone" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.